相似文献/References:
[1]陈国平 陈剑明.多项肿瘤标记物在胃癌诊断中的筛选及应用价值[J].福建医药杂志,2019,41(02):4.
CHEN Guoping,CHEN Jianming..Value of screening and application of multiple combined tumor markers in the diagnosis of gastric cancer[J].FUJIAN MEDICAL JOURNAL,2019,41(5):4.
[2]赵 珅 范南峰 李 惠 刘 捷 俞嘉青 林榕波.阿帕替尼联合紫杉醇化疗方案治疗紫杉醇耐药的晚期胃癌的临床研究[J].福建医药杂志,2020,42(01):16.
ZHAO Shen,FAN Nanfeng,LI Hui,et al.Clinical study of apatinib combined with paclitaxel chemotherapy in the treatment of paclitaxel-resistant advanced gastric cancer[J].FUJIAN MEDICAL JOURNAL,2020,42(5):16.
[3]吕美玲,赖丽萍,吕冬梅,等.干扰MS4A8对苦参碱抑制胃癌细胞生长的影响[J].福建医药杂志,2023,45(05):98.
[4]沈惠群,沈松菲.5-Aza-CdR对胃癌中SOX17基因表达的影响[J].福建医药杂志,2024,46(01):24.[doi:10.20148/j.fmj.2024.01.007]